B. J. Maron, J. S. Gottdiener, and S. E. Epstein, Patterns and significance of the distribution of left ventricular hypertrophy in a large population of patients with hypertrophic cardiomyopathy: A wide-angle two-dimensional echocardiographic study, The American Journal of Cardiology, vol.45, issue.2, pp.418-428, 1981.
DOI : 10.1016/0002-9149(80)91074-7

P. M. Elliott, Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy, Heart, vol.92, issue.6, pp.785-791, 2006.
DOI : 10.1136/hrt.2005.068577

P. Melacini, Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy, European Heart Journal, vol.31, issue.17, pp.2111-2123, 2010.
DOI : 10.1093/eurheartj/ehq136

O. P. Guttmann, Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA), European Journal of Heart Failure, vol.30, issue.Suppl 1, pp.837-845, 2015.
DOI : 10.1093/eurheartj/ehp327

C. Semsarian, J. Ingles, M. S. Maron, and B. J. Maron, New Perspectives on the Prevalence of??Hypertrophic Cardiomyopathy, Journal of the American College of Cardiology, vol.65, issue.12, pp.1249-1254, 2015.
DOI : 10.1016/j.jacc.2015.01.019

A. J. Ullal, R. S. Abdelfattah, E. A. Ashley, and V. F. Froelicher, Hypertrophic Cardiomyopathy as a Cause of??Sudden Cardiac Death in the Young: A Meta-Analysis, The American Journal of Medicine, vol.129, issue.5, pp.486-496, 2016.
DOI : 10.1016/j.amjmed.2015.12.027

R. E. Eckart, Sudden Death in Young Adults, Journal of the American College of Cardiology, vol.58, issue.12, pp.1254-1261, 2011.
DOI : 10.1016/j.jacc.2011.01.049

B. J. Maron, M. S. Maron, and . Hypertrophic-cardiomyopathy, Hypertrophic cardiomyopathy, The Lancet, vol.381, issue.9862, pp.242-255, 2013.
DOI : 10.1016/S0140-6736(12)60397-3

A. G. Bick, Burden of Rare Sarcomere Gene Variants in the Framingham and Jackson Heart Study Cohorts, The American Journal of Human Genetics, vol.91, issue.3, pp.513-519, 2012.
DOI : 10.1016/j.ajhg.2012.07.017

E. Orenes-piñero, Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy, QJM, vol.107, issue.8, pp.613-621, 2014.
DOI : 10.1093/qjmed/hcu046

S. Wang, Worse prognosis with gene mutations of beta-myosin heavy chain than myosinbinding protein C in Chinese patients with hypertrophic cardiomyopathy, Clin Cardiol, vol.31, pp.114-118, 2008.

P. Charron, Clinical Features and Prognostic Implications of Familial Hypertrophic Cardiomyopathy Related to the Cardiac Myosin-Binding Protein C Gene, Circulation, vol.97, issue.22, pp.2230-2236, 1998.
DOI : 10.1161/01.CIR.97.22.2230

G. Millat, Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy, European Journal of Medical Genetics, vol.53, issue.5, pp.261-267, 2010.
DOI : 10.1016/j.ejmg.2010.07.007

URL : https://hal.archives-ouvertes.fr/hal-01017146

M. S. Maron, Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy, Circulation: Cardiovascular Imaging, vol.5, issue.4, pp.441-447, 2012.
DOI : 10.1161/CIRCIMAGING.112.972760

R. Coppini, Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations, Journal of the American College of Cardiology, vol.64, issue.24, pp.2589-2600, 2014.
DOI : 10.1016/j.jacc.2014.09.059

L. Deprez and R. H. , Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene, Journal of Medical Genetics, vol.43, issue.10, pp.829-832, 2006.
DOI : 10.1136/jmg.2005.040329

M. García-castro, Hypertrophic cardiomyopathy linked to homozygosity for a new mutation in the myosin-binding protein C gene (A627V) suggests a dosage effect, International Journal of Cardiology, vol.102, issue.3, pp.501-507, 2005.
DOI : 10.1016/j.ijcard.2004.05.060

B. Jeschke, A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated ??-myosin heavy chain genes, Human Genetics, vol.102, issue.3, pp.299-304, 1998.
DOI : 10.1007/s004390050695

M. F. Ortiz, A Homozygous MYBPC3 Gene Mutation Associated With a Severe Phenotype and a High Risk of Sudden Death in a Family With Hypertrophic Cardiomyopathy, Revista Espa??ola de Cardiolog??a (English Edition), vol.62, issue.5, pp.572-575, 2009.
DOI : 10.1016/S1885-5857(09)71841-9

M. D. Bashyam, G. R. Savithri, M. Gopikrishna, and C. Narasimhan, A p.R870H mutation in the beta-cardiac myosin heavy chain 7 gene causes familial hypertrophic cardiomyopathy in several members of an Indian family, Canadian Journal of Cardiology, vol.23, issue.10, pp.788-790, 2007.
DOI : 10.1016/S0828-282X(07)70828-0

C. Y. Ho, Homozygous Mutation in Cardiac Troponin T : Implications for Hypertrophic Cardiomyopathy, Circulation, vol.102, issue.16, pp.1950-1955, 2000.
DOI : 10.1161/01.CIR.102.16.1950

K. Zahka, Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish, Heart, vol.94, issue.10, pp.1326-1330, 2008.
DOI : 10.1136/hrt.2007.127241

/. Authors and . Force, 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Eur. Heart J, vol.35, pp.2733-2779, 2014.

C. Y. Ho, Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy, New England Journal of Medicine, vol.363, issue.6
DOI : 10.1056/NEJMoa1002659

W. I. Jung, Differences in Cardiac Energetics Between Patients With Familial and Nonfamilial Hypertrophic Cardiomyopathy, Circulation, vol.101, issue.12, p.121, 2000.
DOI : 10.1161/01.CIR.101.12.e121

J. G. Crilley, Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy, Journal of the American College of Cardiology, vol.41, issue.10, pp.1776-1782, 2003.
DOI : 10.1016/S0735-1097(02)03009-7

M. R. Abraham, Creatine Kinase Adenosine Triphosphate and Phosphocreatine Energy Supply in a Single Kindred of Patients With Hypertrophic Cardiomyopathy, The American Journal of Cardiology, vol.112, issue.6, pp.861-866, 2013.
DOI : 10.1016/j.amjcard.2013.05.017

S. A. Timmer, Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction, European Journal of Heart Failure, vol.12, issue.12
DOI : 10.1186/1532-429X-12-13

S. Cortassa, A Computational Model Integrating Electrophysiology, Contraction, and Mitochondrial Bioenergetics in the Ventricular Myocyte, Biophysical Journal, vol.91, issue.4, pp.1564-1589, 2006.
DOI : 10.1529/biophysj.105.076174

P. R. Territo, V. K. Mootha, S. A. French, and R. S. Balaban, Ca(2+) activation of heart mitochondrial oxidative phosphorylation: role of the F(0)/F(1)-ATPase, Am. J. Physiol., Cell Physiol, vol.278, pp.423-435, 2000.

C. Maack and B. O-'rourke, Excitation-contraction coupling and mitochondrial energetics, Basic Research in Cardiology, vol.507, issue.257
DOI : 10.1161/01.RES.77.1.88

K. Nakamura, Relationship Between Oxidative Stress and Systolic Dysfunction in Patients With Hypertrophic Cardiomyopathy, Journal of Cardiac Failure, vol.11, issue.2, pp.117-123, 2005.
DOI : 10.1016/j.cardfail.2004.05.005

B. J. Maron, The Electrocardiogram as a Diagnostic Tool for Hypertrophic Cardiomyopathy: Revisited, Annals of Noninvasive Electrocardiology, vol.35, issue.4
DOI : 10.1161/01.CIR.94.4.850

N. K. Lakdawala, Electrocardiographic Features of Sarcomere Mutation Carriers With and Without Clinically Overt Hypertrophic Cardiomyopathy, The American Journal of Cardiology, vol.108, issue.11, pp.1606-1613, 2011.
DOI : 10.1016/j.amjcard.2011.07.019

P. Gosse, ECG detection of left ventricular hypertrophy, Journal of Hypertension, vol.30, issue.5, pp.990-996, 2012.
DOI : 10.1097/HJH.0b013e3283524961

S. Köse, Detection of patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation during sinus rhythm by P-wave dispersion, Clinical Cardiology, vol.22, issue.10, pp.431-434, 2003.
DOI : 10.1016/0002-8703(79)90254-0

K. Tuluce, Predictors of Future Atrial Fibrillation Development in Patients with Hypertrophic Cardiomyopathy: A Prospective Follow-Up Study, Echocardiography, vol.58, issue.3, pp.379-385, 2016.
DOI : 10.1161/01.RES.58.3.356

P. Charron, Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population, International Journal of Cardiology, vol.90, issue.1, pp.33-38, 2003.
DOI : 10.1016/S0167-5273(02)00534-X

O. 'mahony and C. , A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD), European Heart Journal, vol.35, issue.30, pp.2010-2020, 2014.
DOI : 10.1093/eurheartj/eht439

B. J. Maron, A. Pelliccia, and P. Spirito, Cardiac Disease in Young Trained Athletes : Insights Into Methods for Distinguishing Athlete's Heart From Structural Heart Disease, With Particular Emphasis on Hypertrophic Cardiomyopathy, Circulation, vol.91, issue.5, pp.1596-1601, 1995.
DOI : 10.1161/01.CIR.91.5.1596

J. Binder, Echocardiography-Guided Genetic Testing in Hypertrophic Cardiomyopathy: Septal Morphological Features Predict the Presence of Myofilament Mutations, Mayo Clinic Proceedings, vol.81, issue.4, pp.459-467, 2006.
DOI : 10.4065/81.4.459

J. Peyrou, Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography, The International Journal of Cardiovascular Imaging, vol.101, issue.4, 2016.
DOI : 10.1161/CIRCRESAHA.107.153650

C. Gruner, Significance of left ventricular apical???basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy, European Heart Journal, vol.35, issue.39, pp.2706-2713, 2014.
DOI : 10.1093/eurheartj/ehu154

H. G. Klues, W. C. Roberts, and B. J. Maron, Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction, Circulation, vol.84, issue.3, pp.1188-1197, 1991.
DOI : 10.1161/01.CIR.84.3.1188

R. A. Levine, Papillary Muscle Displacement Causes Systolic Anterior Motion of the Mitral Valve : Experimental Validation and Insights Into the Mechanism of Subaortic Obstruction, Circulation, vol.91, issue.4, pp.1189-1195, 1995.
DOI : 10.1161/01.CIR.91.4.1189

D. H. Kwon, Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy, Heart, vol.94, issue.10, pp.1295-1301, 2008.
DOI : 10.1136/hrt.2007.118018

P. Patel, Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography, Circulation: Cardiovascular Imaging, vol.8, issue.7, p.3132, 2015.
DOI : 10.1161/CIRCIMAGING.115.003132

E. P. Teo, J. G. Teoh, and J. Hung, Mitral valve and papillary muscle abnormalities in hypertrophic obstructive cardiomyopathy, Current Opinion in Cardiology, vol.30, issue.5, pp.475-482, 2015.
DOI : 10.1097/HCO.0000000000000200

R. Ro, Vector Flow Mapping in Obstructive Hypertrophic Cardiomyopathy to Assess the Relationship of Early Systolic Left Ventricular Flow and the Mitral Valve, Journal of the American College of Cardiology, vol.64, issue.19, pp.1984-1995, 2014.
DOI : 10.1016/j.jacc.2014.04.090

R. A. Levine, E. Schwammenthal, and J. Song, Diastolic Leading to Systolic Anterior Motion, Journal of the American College of Cardiology, vol.64, issue.19, 1996.
DOI : 10.1016/j.jacc.2014.09.010

S. Carasso, Systolic Myocardial Mechanics in Hypertrophic Cardiomyopathy: Novel Concepts and Implications for Clinical Status, Journal of the American Society of Echocardiography, vol.21, issue.6, pp.675-683, 2008.
DOI : 10.1016/j.echo.2007.10.021

S. Lafitte, Paradoxical Response to Exercise in Asymptomatic Hypertrophic Cardiomyopathy, Journal of the American College of Cardiology, vol.62, issue.9, pp.842-850, 2013.
DOI : 10.1016/j.jacc.2013.06.007

E. J. Chen, W. K. Jenkins, and W. O-'brien, Performance of ultrasonic speckle tracking in various tissues, The Journal of the Acoustical Society of America, vol.98, issue.3, pp.1273-1278, 1995.
DOI : 10.1121/1.414453

D. Phelan, Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis, Heart, vol.98, issue.19, pp.1442-1448, 2012.
DOI : 10.1136/heartjnl-2012-302353

E. Correia, Longitudinal Left Ventricular Strain in Hypertrophic Cardiomyopathy: Correlation with Nonsustained Ventricular Tachycardia, Echocardiography, vol.22, issue.4, pp.709-714, 2011.
DOI : 10.1016/j.echo.2009.01.001

P. Debonnaire, Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients, The International Journal of Cardiovascular Imaging, vol.14, issue.3
DOI : 10.1093/europace/eur362

P. Reant, Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy, Heart, vol.25, issue.10, pp.741-747, 2016.
DOI : 10.1016/j.echo.2012.08.007

C. Rickers, Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy, Circulation, vol.112, issue.6, pp.855-861, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.507723

S. F. Nagueh, American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy, Journal of the American Society of Echocardiography, vol.24, issue.5, pp.473-498, 2011.
DOI : 10.1016/j.echo.2011.03.006

J. C. Moon, N. G. Fisher, W. J. Mckenna, and D. J. Pennell, Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography, Heart, vol.90, issue.6
DOI : 10.1136/hrt.2003.014969

Y. Miyaji, Interrelationship between the Myocardial Mass, Fibrosis, BNP, and Clinical Outcomes in Hypertrophic Cardiomyopathy, Internal Medicine, vol.55, issue.10, pp.1261-1268, 2016.
DOI : 10.2169/internalmedicine.55.6480

W. P. Brouwer, Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers, European Heart Journal - Cardiovascular Imaging, vol.13, issue.4, pp.292-297, 2012.
DOI : 10.1093/ehjci/jes005

T. Germans, Structural Abnormalities of the Inferoseptal Left Ventricular Wall Detected by Cardiac Magnetic Resonance Imaging in Carriers of Hypertrophic Cardiomyopathy Mutations, Journal of the American College of Cardiology, vol.48, issue.12
DOI : 10.1016/j.jacc.2006.08.036

J. C. Moon, The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy, Journal of the American College of Cardiology, vol.43, issue.12, pp.2260-2264, 2004.
DOI : 10.1016/j.jacc.2004.03.035

J. J. Green, J. S. Berger, C. M. Kramer, and M. Salerno, Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy, JACC: Cardiovascular Imaging, vol.5, issue.4, pp.370-377, 2012.
DOI : 10.1016/j.jcmg.2011.11.021

Z. Weng, Prognostic Value of LGE-CMR in HCM, JACC: Cardiovascular Imaging, vol.9, issue.12, 2016.
DOI : 10.1016/j.jcmg.2016.02.031

A. Briasoulis, S. Mallikethi-reddy, M. Palla, I. Alesh, and L. Afonso, Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis, Heart, vol.114, issue.17, pp.1406-1411, 2015.
DOI : 10.1161/CIRCULATIONAHA.105.583500

R. Rubinshtein, Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy, Circulation: Heart Failure, vol.3, issue.1, pp.51-58, 2010.
DOI : 10.1161/CIRCHEARTFAILURE.109.854026

J. C. Moon, Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance, Journal of the American College of Cardiology, vol.41, issue.9, pp.1561-1567, 2003.
DOI : 10.1016/S0735-1097(03)00189-X

S. J. Flacke, S. E. Fischer, and C. H. Lorenz, Measurement of the Gadopentetate Dimeglumine Partition Coefficient in Human Myocardium in Vivo: Normal Distribution and Elevation in Acute and Chronic Infarction, Radiology, vol.218, issue.3, pp.703-710, 2001.
DOI : 10.1148/radiology.218.3.r01fe18703

C. Y. Ho, T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy, Circulation: Cardiovascular Imaging, vol.6, issue.3, pp.415-422, 2013.
DOI : 10.1161/CIRCIMAGING.112.000333

D. M. Sado, Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping, Circulation: Cardiovascular Imaging, vol.6, issue.3, pp.392-398, 2013.
DOI : 10.1161/CIRCIMAGING.112.000070

D. M. Sado, mapping using cardiovascular magnetic resonance for iron overload, Journal of Magnetic Resonance Imaging, vol.32, issue.Pt 5, pp.1505-1511, 2015.
DOI : 10.1093/eurheartj/ehq443

K. M. Harris, Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy, Circulation, vol.114, issue.3, pp.216-225, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.583500

O. P. Guttmann, M. S. Rahman, C. O-'mahony, A. Anastasakis, and P. M. Elliott, Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review, Heart, vol.99, issue.(Suppl 1), pp.465-472, 2014.
DOI : 10.1016/j.amjcard.2006.12.087

K. Robinson, Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study, J. Am

F. Cecchi, Hypertrophic cardiomyopathy in tuscany: Clinical course and outcome in an unselected regional population, Journal of the American College of Cardiology, vol.26, issue.6, pp.1529-1536, 1995.
DOI : 10.1016/0735-1097(95)00353-3

I. Olivotto, Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy, Circulation, vol.104, issue.21, pp.2517-2524, 2001.
DOI : 10.1161/hc4601.097997

M. Losi, Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy, The American Journal of Cardiology, vol.94, issue.7, pp.895-900, 2004.
DOI : 10.1016/j.amjcard.2004.06.024

S. Nistri, Prognostic Significance of Left Atrial Size in Patients With Hypertrophic Cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy), The American Journal of Cardiology, vol.98, issue.7, pp.960-965, 2006.
DOI : 10.1016/j.amjcard.2006.05.013

T. Kubo, Clinical Impact of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy, Circulation Journal, vol.73, issue.9
DOI : 10.1253/circj.CJ-09-0140

K. C. Siontis, Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High-Risk Population, Journal of the American Heart Association, vol.3, issue.3, p.1002, 2014.
DOI : 10.1161/JAHA.114.001002

C. Iio, Characteristics of Left Atrial Deformation Parameters and Their Prognostic Impact in Patients with Pathological Left Ventricular Hypertrophy: Analysis by Speckle Tracking Echocardiography, Echocardiography, vol.104, issue.12, pp.1821-1830, 2015.
DOI : 10.1161/hc4601.097997

B. J. Maron, Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy, J

B. Yashiro, Y. Minami, Y. Terajima, and N. Hagiwara, Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy, Journal of Cardiology, vol.63, issue.6, pp.432-437, 2014.
DOI : 10.1016/j.jjcc.2013.10.011

Y. Minami, Enlarged left atrium and sudden death risk in hypertrophic cardiomyopathy patients with or without atrial fibrillation Topilsky, Y. et al. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy, J Cardiol Circ Heart Fail, vol.4, pp.266-275, 2011.

K. Muthiah, Centrifugal Continuous-Flow Left Ventricular Assist Device in Patients With Hypertrophic Cardiomyopathy, ASAIO Journal, vol.59, issue.2, pp.183-187, 2013.
DOI : 10.1097/MAT.0b013e318286018d

E. Biagini, Heart Transplantation in Hypertrophic Cardiomyopathy, The American Journal of Cardiology, vol.101, issue.3, pp.387-392, 2008.
DOI : 10.1016/j.amjcard.2007.09.085

A. S. Adabag, Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance, Journal of the American College of Cardiology, vol.51, issue.14, pp.1369-1374, 2008.
DOI : 10.1016/j.jacc.2007.11.071

A. J. Mclellan, Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy, J. Cardiovasc

T. Suk, C. Edwards, H. Hart, and J. P. Christiansen, Myocardial Scar Detected by Contrast-Enhanced Cardiac Magnetic Resonance Imaging is Associated with Ventricular Tachycardia in Hypertrophic Cardiomyopathy Patients, Heart, Lung and Circulation, vol.17, issue.5, pp.370-374, 2008.
DOI : 10.1016/j.hlc.2008.03.080

R. H. Chan, Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy, Circulation, vol.130, issue.6, pp.484-495, 2014.
DOI : 10.1161/CIRCULATIONAHA.113.007094

D. Salvo and G. , Non Sustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy and New Ultrasonic Derived Parameters, Journal of the American Society of Echocardiography, vol.23, issue.6, pp.581-590, 2010.
DOI : 10.1016/j.echo.2010.02.013

M. Jalanko, Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy, Annals of Medicine, vol.48, issue.6, pp.1-11, 2016.
DOI : 10.1007/s00109-002-0323-9

B. Piva-e-mattos, M. A. Torres, V. C. Freitas, . De, F. L. Scolari et al., Ventricular arrhythmias and left ventricular hypertrophy in hypertrophic cardiomyopathy, Arq. Bras. Cardiol, vol.100, pp.452-459, 2013.

A. Hedman, Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thickness and clinical markers of sudden cardiac death in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the ??-tropomyosin gene, Journal of Molecular and Cellular Cardiology, vol.36, issue.1
DOI : 10.1016/j.yjmcc.2003.10.003

J. P. Zachariah, Circulating Matrix Metalloproteinases in Adolescents With Hypertrophic Cardiomyopathy and Ventricular Arrhythmia, Circulation: Heart Failure, vol.5, issue.4, pp.462-466, 2012.
DOI : 10.1161/CIRCHEARTFAILURE.111.966200

B. J. Maron, D. D. Savage, J. K. Wolfson, and S. E. Epstein, Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study, The American Journal of Cardiology, vol.48, issue.2, pp.252-257, 1981.
DOI : 10.1016/0002-9149(81)90604-4

P. Spirito, Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia, Circulation, vol.90, issue.6, pp.2743-2747, 1994.
DOI : 10.1161/01.CIR.90.6.2743

L. Monserrat, Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients, ACC Current Journal Review, vol.13, issue.1, pp.873-879, 2003.
DOI : 10.1016/j.accreview.2003.10.024

P. Spirito, Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy, Circulation, vol.119, issue.13, pp.1703-1710, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.798314

P. M. Elliott, Sudden death in hypertrophic cardiomyopathy: identification of high risk patients, Journal of the American College of Cardiology, vol.36, issue.7, pp.2212-2218, 2000.
DOI : 10.1016/S0735-1097(00)01003-2

P. Spirito, Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy, New England Journal of Medicine, vol.342, issue.24, pp.1778-1785, 2000.
DOI : 10.1056/NEJM200006153422403

P. M. Elliott, J. R. Gimeno-blanes, N. G. Mahon, J. D. Poloniecki, and W. J. Mckenna, Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy, The Lancet, vol.357, issue.9254, pp.420-424, 2001.
DOI : 10.1016/S0140-6736(00)04005-8

S. Maki, Predictors of sudden cardiac death in hypertrophic cardiomyopathy, The American Journal of Cardiology, vol.82, issue.6, pp.774-778, 1998.
DOI : 10.1016/S0002-9149(98)00455-X

M. S. Maron, Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy, New England Journal of Medicine, vol.348, issue.4, pp.295-303, 2003.
DOI : 10.1056/NEJMoa021332

P. Elliott, J. Gimeno, M. Tomé, and W. Mckenna, Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy, European Heart Journal, vol.27, issue.24, pp.3073-3074, 2006.
DOI : 10.1093/eurheartj/ehl383

A. G. Adelman, P. M. Shah, R. Gramiak, and E. D. Wigle, Long-term propranolol therapy in muscular subaortic stenosis., Heart, vol.32, issue.6, pp.804-811, 1970.
DOI : 10.1136/hrt.32.6.804

M. D. Flamm, D. C. Harrison, and E. W. Hancock, Muscular Subaortic Stenosis: Prevention of Outflow Obstruction with Propranolol, Circulation, vol.38, issue.5, pp.846-858, 1968.
DOI : 10.1161/01.CIR.38.5.846

M. Tendera, A. Wycisk, A. Schneeweiss, L. Polo?ski, and J. Wodniecki, Effect of Sotalol on Arrhythmias and Exercise Tolerance in Patients with Hypertrophic Cardiomyopathy, Cardiology, vol.82, issue.5, pp.335-342, 1993.
DOI : 10.1159/000175883

M. V. Sherrid, Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy, Journal of the American College of Cardiology, vol.45, issue.8, pp.1251-1258, 2005.
DOI : 10.1016/j.jacc.2005.01.012

S. E. Epstein and D. R. Rosing, Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy, Circulation, vol.64, issue.3, pp.437-441, 1981.
DOI : 10.1161/01.CIR.64.3.437

H. Toshima, Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study., Japanese Heart Journal, vol.27, issue.5, pp.701-715, 1986.
DOI : 10.1536/ihj.27.701

S. Betocchi, Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy, Circulation, vol.72, issue.5, pp.1001-1007, 1985.
DOI : 10.1161/01.CIR.72.5.1001

R. Spoladore, M. S. Maron, R. Amato, P. G. Camici, and I. Olivotto, Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence, European Heart Journal, vol.33, issue.14, pp.1724-1733, 2012.
DOI : 10.1093/eurheartj/ehs150

J. J. Mcmurray, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012, Revista Portuguesa de Cardiologia (English Edition), vol.32, issue.7-8, 2012.
DOI : 10.1016/j.repce.2013.10.001

E. Braunwald, E. C. Brockenbrough, and R. L. Frye, Studies on Digitalis: V. Comparison of the Effects of Ouabain on Left Ventricular Dynamics in Valvular Aortic Stenosis and Hypertrophic Subaortic Stenosis, Circulation, vol.26, issue.2, pp.166-173, 1962.
DOI : 10.1161/01.CIR.26.2.166

R. F. Alvares and J. Goodwin, Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs., Heart, vol.48, issue.3, pp.204-212, 1982.
DOI : 10.1136/hrt.48.3.204

J. E. Udelson, Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy, Circulation, vol.79, issue.5, pp.1052-1060, 1989.
DOI : 10.1161/01.CIR.79.5.1052

A. J. Camm, 2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation, Revista Espa??ola de Cardiolog??a (English Edition), vol.66, issue.1, pp.1385-1413, 2012.
DOI : 10.1016/j.rec.2012.11.003

J. Duchateau, Abnormal Left Ventricular Contraction Sequence in Hypertrophic Cardiomyopathy Patients: First Description of Hypersynchrony and Invert Synchrony, Ultrasound in Medicine & Biology, vol.41, issue.6, pp.1632-1639, 2015.
DOI : 10.1016/j.ultrasmedbio.2015.01.027

L. Fananapazir, Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy, Circulation, vol.90, issue.6, pp.2731-2742, 1994.
DOI : 10.1161/01.CIR.90.6.2731

E. Galve, Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study, Heart, vol.96, issue.5, pp.352-356, 2010.
DOI : 10.1136/hrt.2008.158915

X. Jeanrenaud, J. J. Goy, and L. Kappenberger, Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy, The Lancet, vol.339, issue.8805, pp.1318-1323, 1992.
DOI : 10.1016/0140-6736(92)91961-7

C. Linde, F. Gadler, L. Kappenberger, and L. Rydén, Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy, The American Journal of Cardiology, vol.83, issue.6, pp.903-907, 1999.
DOI : 10.1016/S0002-9149(98)01065-0

M. H. Park, D. M. Gilligan, N. L. Bernardo, and O. Topaz, Symptomatic Hypertrophic Obstructive Cardiomyopathy: The Role of Dual-Chamber Pacing, Angiology, vol.11, issue.2, pp.87-94, 1999.
DOI : 10.1016/S0735-1097(98)81770-1

A. G. Morrow, Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients, Circulation, vol.52, issue.1, pp.88-102, 1975.
DOI : 10.1161/01.CIR.52.1.88

J. A. Dearani, S. R. Ommen, B. J. Gersh, H. V. Schaff, and G. K. Danielson, Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy???the Mayo Clinic experience, Nature Clinical Practice Cardiovascular Medicine, vol.44, issue.9, pp.503-512, 2007.
DOI : 10.1161/01.CIR.85.5.1651

R. K. Kaple, Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical Outcomes, The Annals of Thoracic Surgery, vol.85, issue.5, pp.1527-1535, 2008.
DOI : 10.1016/j.athoracsur.2008.01.061

F. A. Schoendube, Long-term Clinical and Echocardiographic Follow-up After Surgical Correction of Hypertrophic Obstructive Cardiomyopathy With Extended Myectomy and Reconstruction of the Subvalvular Mitral Apparatus, Circulation, vol.92, issue.9, pp.122-127, 1995.
DOI : 10.1161/01.CIR.92.9.122

Z. Krajcer, R. D. Leachman, D. A. Cooley, and R. Coronado, Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients, Circulation, vol.80, pp.57-64, 1989.

R. C. Robbins and E. B. Stinson, Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy, The Journal of Thoracic and Cardiovascular Surgery, vol.111, issue.3, pp.586-594, 1996.
DOI : 10.1016/S0022-5223(96)70310-0

S. R. Ommen, Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy, Journal of the American College of Cardiology, vol.46, issue.3, pp.470-476, 2005.
DOI : 10.1016/j.jacc.2005.02.090

M. Y. Desai, Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction, Circulation, vol.128, issue.3, pp.209-216, 2013.
DOI : 10.1161/CIRCULATIONAHA.112.000849

U. Sigwart, Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy, The Lancet, vol.346, issue.8969, pp.211-214, 1995.
DOI : 10.1016/S0140-6736(95)91267-3

P. Sorajja, Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy, Circulation, vol.118, issue.2, pp.131-139, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.738740

P. Sorajja, Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy, Circulation, vol.126, issue.20, pp.2374-2380, 2012.
DOI : 10.1161/CIRCULATIONAHA.111.076257

D. Donna and P. , Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression, Europace, vol.12, issue.3, pp.347-355, 2010.
DOI : 10.1093/europace/euq013

D. Zhao, Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis, Europace, vol.18, issue.4, pp.508-520, 2016.
DOI : 10.1093/europace/euv339

C. Rapezzi, Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases, European Heart Journal, vol.34, issue.19, pp.1448-1458, 2013.
DOI : 10.1093/eurheartj/ehs397

A. Evangelista, European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies, European Journal of Echocardiography, vol.9, issue.4, pp.438-448, 2008.
DOI : 10.1093/ejechocard/jen174

J. T. Kowallick, Quantification of atrial dynamics using cardiovascular magnetic resonance: inter-study reproducibility, Journal of Cardiovascular Magnetic Resonance, vol.130, issue.1, p.36, 2015.
DOI : 10.1161/CIRCULATIONAHA.113.008461

M. D. Cerqueira, Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association, Int J Cardiovasc Imaging, vol.18, pp.539-542, 2002.

R. Beigel, B. Cercek, H. Luo, and R. J. Siegel, Noninvasive Evaluation of Right Atrial Pressure, Journal of the American Society of Echocardiography, vol.26, issue.9, pp.1033-1042, 2013.
DOI : 10.1016/j.echo.2013.06.004

A. P. Yoganathan, E. G. Cape, H. W. Sung, F. P. Williams, and A. Jimoh, Review of hydrodynamic principles for the cardiologist: Applications to the study of blood flow and jets by imaging techniques, Journal of the American College of Cardiology, vol.12, issue.5
DOI : 10.1016/0735-1097(88)92620-4

R. M. Lang, Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography???s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology, Journal of the American Society of Echocardiography, vol.18, issue.12, pp.1440-1463, 2005.
DOI : 10.1016/j.echo.2005.10.005

M. Parsaee, New onset atrial fibrillation after coronary artery bypasses grafting; an evaluation of mechanical left atrial function, Arch Iran Med, vol.17, pp.501-506, 2014.

S. Y. Shin, Impaired Transport Function of the Left Atrium in Patients with Lone Paroxysmal Atrial Fibrillation, Echocardiography, vol.3, issue.1, pp.44-51, 2011.
DOI : 10.1161/CIRCIMAGING.109.865683

Q. Cui, Enhanced Left Atrial Reservoir, Increased Conduit, and Weakened Booster Pump Function in Hypertensive Patients with Paroxysmal Atrial Fibrillation, Hypertension Research, vol.31, issue.3, pp.395-400, 2008.
DOI : 10.1291/hypres.31.395

J. Imanishi, Association of Left Atrial Booster-Pump Function with Heart Failure Symptoms in Patients with Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction, Echocardiography, vol.86, issue.5, pp.758-767, 2015.
DOI : 10.1136/heart.86.4.381

T. Hirose, Left atrial function assessed by speckle tracking echocardiography as a predictor of new-onset non-valvular atrial fibrillation: results from a prospective study in 580 adults, European Heart Journal - Cardiovascular Imaging, vol.13, issue.3, pp.243-250, 2012.
DOI : 10.1093/ejechocard/jer251

F. Girolami, Novel ??-Actinin 2 Variant Associated With Familial Hypertrophic Cardiomyopathy and Juvenile Atrial Arrhythmias: A Massively Parallel Sequencing Study, Circulation: Cardiovascular Genetics, vol.7, issue.6, pp.741-750, 2014.
DOI : 10.1161/CIRCGENETICS.113.000486